Researchers draw parallels between soil and human health to promote sustainable land management

In the bid to lock up patent rights to a grow­ing suite of gene edit­ing tech­nolo­gies, Ar­bor Biotech­nolo­gies has ac­quired a small start­up found­ed by

Pediatric-onset multiple sclerosis (MS) patients showed progression independent of relapse activity (PIRA) even when they were relatively young, a prospective cohort study found. Confirmed PIRA

In­fin­i­ty Phar­ma­ceu­ti­cals is scram­bling to re­duce its “burn rate” af­ter the pro­posed merg­er with MEI Phar­ma fell through, turn­ing to lay­offs and a down­sized board